Service d'Hématologie Biologique, Hôpital Pitié-SalpêtrièreParis, France
NA
(1553652) TRAF3 inactivation in chronic lymphocytic leukemia enhances metabolic cellular plasticity through metabolic reprogramming and associates with adverse prognosis
Saturday, October 7, 202311:40 AM – 11:50 AM EDT
(1547411) Minimal residual disease-guided combination of ibrutinib and venetoclax compared to FCR in untreated patients with CLL of intermediate risk : interim results of MRD kinetics in the ERADIC trial from the FILO group
Sunday, October 8, 20239:25 AM – 9:35 AM EDT